| Mario J Imola, MD | |
|
3600 S Logan St, Suite 100, Englewood, CO 80113-3766 | |
| (303) 839-7980 | |
| (303) 839-7936 |
| Full Name | Mario J Imola |
|---|---|
| Gender | Male |
| Speciality | Plastic And Reconstructive Surgery |
| Experience | 37 Years |
| Location | 3600 S Logan St, Englewood, Colorado |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1932101490 | NPI | - | NPPES |
| 841553144 | Other | CO | TAX ID |
| 117142900 | Medicaid | WY | |
| 95739831 | Medicaid | CO |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207YS0123X | Otolaryngology - Facial Plastic Surgery | 38335 (Colorado) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Hca-healthone Dba Swedish Medical Center | Englewood, CO | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Colorado Facial Plastic Surgery Center Inc | 6305977745 | 2 |
News Archive
Creabilis SA, a clinical stage European biotechnology company addressing unmet medical needs in dermatology, today announced positive results from its Phase IIa study of its lead product CT327 in psoriasis vulgaris.
New research led by neuroscientists at Tufts University School of Medicine suggests the prolonged antidepressant effects of allopregnanolone, a neuroactive steroid used therapeutically to treat postpartum depression, may involve the ability of the compound to modify communication in an area of the brain important for mood and emotion regulation.
Corneal diseases are among the most common causes of visual impairment and blindness, with Fuchs endothelial corneal dystrophy (FECD), a gradual swelling and clouding of the cornea, being the most common reason for eventual corneal transplants.
A new method enables genes in living T-cells in mice to be modified quickly and efficiently. It makes use of plasmids, a tried-and-tested method of genetic engineering.
Tiny gold particles can help doctors detect tumor cells circulating in the blood of patients with head and neck cancer, researchers at Emory and Georgia Tech have found.
› Verified 9 days ago
| Entity Name | Colorado Facial Plastic Surgery Center Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1114068376 PECOS PAC ID: 6305977745 Enrollment ID: O20100628001032 |
News Archive
Creabilis SA, a clinical stage European biotechnology company addressing unmet medical needs in dermatology, today announced positive results from its Phase IIa study of its lead product CT327 in psoriasis vulgaris.
New research led by neuroscientists at Tufts University School of Medicine suggests the prolonged antidepressant effects of allopregnanolone, a neuroactive steroid used therapeutically to treat postpartum depression, may involve the ability of the compound to modify communication in an area of the brain important for mood and emotion regulation.
Corneal diseases are among the most common causes of visual impairment and blindness, with Fuchs endothelial corneal dystrophy (FECD), a gradual swelling and clouding of the cornea, being the most common reason for eventual corneal transplants.
A new method enables genes in living T-cells in mice to be modified quickly and efficiently. It makes use of plasmids, a tried-and-tested method of genetic engineering.
Tiny gold particles can help doctors detect tumor cells circulating in the blood of patients with head and neck cancer, researchers at Emory and Georgia Tech have found.
› Verified 9 days ago
| Entity Name | Trauma And Emergency Subspecialty Surgeons Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1740543933 PECOS PAC ID: 1951559293 Enrollment ID: O20120912000182 |
News Archive
Creabilis SA, a clinical stage European biotechnology company addressing unmet medical needs in dermatology, today announced positive results from its Phase IIa study of its lead product CT327 in psoriasis vulgaris.
New research led by neuroscientists at Tufts University School of Medicine suggests the prolonged antidepressant effects of allopregnanolone, a neuroactive steroid used therapeutically to treat postpartum depression, may involve the ability of the compound to modify communication in an area of the brain important for mood and emotion regulation.
Corneal diseases are among the most common causes of visual impairment and blindness, with Fuchs endothelial corneal dystrophy (FECD), a gradual swelling and clouding of the cornea, being the most common reason for eventual corneal transplants.
A new method enables genes in living T-cells in mice to be modified quickly and efficiently. It makes use of plasmids, a tried-and-tested method of genetic engineering.
Tiny gold particles can help doctors detect tumor cells circulating in the blood of patients with head and neck cancer, researchers at Emory and Georgia Tech have found.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mario J Imola, MD 3600 S Logan St, Suite 100, Englewood, CO 80113-3766 Ph: (303) 839-7980 | Mario J Imola, MD 3600 S Logan St, Suite 100, Englewood, CO 80113-3766 Ph: (303) 839-7980 |
News Archive
Creabilis SA, a clinical stage European biotechnology company addressing unmet medical needs in dermatology, today announced positive results from its Phase IIa study of its lead product CT327 in psoriasis vulgaris.
New research led by neuroscientists at Tufts University School of Medicine suggests the prolonged antidepressant effects of allopregnanolone, a neuroactive steroid used therapeutically to treat postpartum depression, may involve the ability of the compound to modify communication in an area of the brain important for mood and emotion regulation.
Corneal diseases are among the most common causes of visual impairment and blindness, with Fuchs endothelial corneal dystrophy (FECD), a gradual swelling and clouding of the cornea, being the most common reason for eventual corneal transplants.
A new method enables genes in living T-cells in mice to be modified quickly and efficiently. It makes use of plasmids, a tried-and-tested method of genetic engineering.
Tiny gold particles can help doctors detect tumor cells circulating in the blood of patients with head and neck cancer, researchers at Emory and Georgia Tech have found.
› Verified 9 days ago
Andre L Reed, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 701 E Hampden Ave Ste 420, Englewood, CO 80113 Phone: 303-781-0404 Fax: 303-781-0804 | |
Dr. Andrew J Nemechek, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 701 E Hampden Ave Ste 225, Englewood, CO 80113 Phone: 303-788-9200 Fax: 303-781-4368 | |
Dr. Jeffrey Le Schmidt, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 125 Inverness Dr E, Suite 250, Englewood, CO 80112 Phone: 720-443-2235 | |
Paul G Van Der Sloot, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 701 E Hampden Ave Ste 225, Englewood, CO 80113 Phone: 303-788-9200 Fax: 303-781-4368 | |
David C Kelsall, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 601 E Hampden Avenue, Suite 430, Englewood, CO 80113 Phone: 303-783-9220 Fax: 303-806-6292 | |
Dr. Steven Briggs Aragon, MD, DDS Otolaryngology Medicare: Not Enrolled in Medicare Practice Location: 125 Inverness Dr E, Suite 100, Englewood, CO 80112 Phone: 303-773-8228 Fax: 720-895-8333 | |
Emily Sarah Misch, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 500 E Hampden Ave Ste 300, Englewood, CO 80113 Phone: 330-714-6937 |